This inventor holds 3 USPTO granted patents and 5 published patent applications and 3 EPO patents. Top assignee: Receptos, Inc.. Active years: 2021-2022.
Location History:
- Summit, NJ (US) (2021)
- San Diego, CA (US) (2021 - 2022)
Company Filing History:
Years Active: 2021-2022
Title: The Innovations of Philip Turnbull
Introduction
Philip Turnbull is a notable inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of GLP-1 receptor modulators. With a total of three patents to his name, Turnbull's work has the potential to impact therapeutic practices significantly.
Latest Patents
Turnbull's latest patents include innovative compounds that modulate the glucagon-like peptide 1 (GLP-1) receptor. These compounds are designed for various applications, including methods of synthesis and therapeutic use. One of his notable patents involves the dimethylaminoethanol salt of a GLP-1 receptor modulator, which is a crystalline compound with specific structural characteristics. This invention aims to enhance the efficacy of treatments related to metabolic disorders.
Career Highlights
Philip Turnbull is currently associated with Receptos, Inc., where he continues to advance his research and development efforts. His work at the company focuses on creating novel therapeutic solutions that address critical health issues. Turnbull's dedication to innovation in the pharmaceutical industry is evident through his successful patent applications.
Collaborations
Throughout his career, Turnbull has collaborated with talented individuals such as Junko Tamiya and Adam Richard Yeager. These partnerships have fostered a creative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.
Conclusion
Philip Turnbull's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work on GLP-1 receptor modulators showcases the potential for innovative solutions in therapeutic applications.